-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903. Health Services and Quality Improvement: Myeloid Malignancies: Poster III

Symposia: Health Services and Quality Improvement: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jennifer E. Vaughn, MD, MPH1, Quihong Zhao1*, Michael Marcucci1*, Nidhi Sharma, PhD2*, Alice Mims, MD3, Allyson Waller, PharmD, BCOP4* and Jeff Stein, Ph.D.5*

1Division of Hematology, The Ohio State University Medical Center, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
3The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
5Center for Health Behaviors Research/ Fralin Biomedical Research Institute, Virginia Tech, Roanoke, VA

Pilar Lancho Lavilla, MD1*, Miguel Lopez-Esteban, MD1*, Javier Ortiz-Alonso, MD, PhD2,3,4,5*, Gracia Fajardo-Tórtola, MD2*, Patricia Font Lopez, MD1*, Marina Gomez Llobell, MD, MS6*, Jose Antonio Serra Resach, MD, PhD2,3,4,5*, Ana Perez-Corral, MD1*, Isabel Regalado Artamendi, MD1*, Mónica Ballesteros Andrés, MD, PhD1*, Carolina Martinez-Laperche, PhD1,7*, Gloria Figaredo Garcia-Mina, MD1*, Raquel Fernández González, PhD1,7*, Carlos Jiménez, MD1, Diego Conde Royo, MD1*, Cristina Pascual Izquierdo, MD, PhD1*, María Teresa Vidán, MD, PhD2,3,4,5*, Ramon García-Sanz, MD, PhD1,8 and Gabriela Rodriguez Macias, MD9

1Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2Geriatrics Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
3Biopathology of Aging Group, Instituto de Investigacion Sanitaria Hospital General Universitario Gregorio Marañón, Madrid, Spain
4Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain
5Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
6Department of Hematology, Gregorio Marañón Hospital, Madrid, NY, Spain
7Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Madrid, Spain
8Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
9Department of Hematology, Hospital Universitario Gregorio Maranon, Madrid, Spain

Jaime M. Preussler, MS1, Christa L Meyer, MS2* and Marguerite Burns, PhD3*

1NMDP, Center for International Blood and Marrow Transplant Research (CIBMTR), Minneapolis, WI
2CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN
3Population Health Sciences, University of Wisconsin-Madison, Madison, WI

Ehab L. Atallah, MD1, Michael S. Broder, MD, MSHS2*, Onyee Chan, MD3*, Hannah Dalglish, MPH2*, Kathryn E. Flynn, PhD1*, Jeffrey Gilreath, PharmD4, Marisa Hine, NP5*, Anthony M. Hunter, MD6, Michael J. Mauro, MD7, Javier Pinilla-Ibarz, MD, PhD3, Lindsay A.M. Rein, MD8, Neil P. Shah, MD, PhD9, Evan Stemper10*, Srinivas K Tantravahi, MD4 and Jay Yang, MD11

1Medical College of Wisconsin, Milwaukee, WI
2PHAR (Partnership for Health Analytic Research), Beverly Hills, CA
3Moffitt Cancer Center, Tampa, FL
4Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
5Memorial Sloan Kettering Cancer Center, New York, NY
6Emory University Winship Cancer Institute, Atlanta, GA
7Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
8Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC
9University of California San Francisco, San Francisco, CA
10University of Wisconsin-Eau Claire, Eau Claire, WI
11Karmanos Cancer Institute, Detroit, MI

Nora Balas, PhD1*, Joshua Richman2*, Wendy Landier, PhD3*, Sadeep Shrestha, PhD4*, Katia J Bruxvoort, PhD5*, Lindsey Hageman, MPH1*, Qingrui Meng, MS3*, Elizabeth Ross5*, Alysia Bosworth, BA6*, Hok Sreng Te7*, F. Lennie Wong, PhD8, Ravi Bhatia, MD9, Stephen J. Forman, MD, FACP10, Saro Armenian, DO, MPH6, Daniel Weisdorf, MD7 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama At Birmingham, Birmingham, AL
4School of Public Health, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL
6City of Hope National Medical Center, Duarte, CA
7University of Minnesota, Minneapolis, MN
8City of Hope, Duarte, CA
9Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
10Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Marissa Locastro, MD1, Ying Wang, MS2*, Soroush Mortaz-Hedjri, MD MSc2*, Danielle Frumusa, PA2*, Tracy Natale, NP2*, Jessica Cohen, MD2*, Nicole Yates, NP3*, Jenna Podlucky, NP3*, Tristan Yu4*, Thomas Carroll, MD, PhD2*, Jane L. Liesveld, MD5, Megan Baumgart, MD3*, Sandra Sabtka, LMSW3*, Dwight Hettler, MS, RN, OCN, NE-BC3*, Nicole Kaplan, JD, MBA3*, Jason H. Mendler, MD, PhD2 and Kah Poh Loh, MD, MBBCH BAO, MS6

1University of Wisconsin Hospitals and Clinics, Madison, WI
2University of Rochester Medical Center, Rochester, NY
3University of Rochester Medical Center, Rochester
4University of Rochester, Rochester
5Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
6University of Rochester, Rochester, NY

Maria Diez-Campelo, MD, PhD1*, Elizabeth Esterberg2*, Ravi K. Goyal, PhD3*, Mrudula B. Glassberg4*, Aylin Yucel, PhD5*, Julien Rombi, MA6*, Keith L. Davis, MA2*, Maria Jimenez, MPH2*, Dimana Miteva7*, Ahmed Hnoosh8* and Ulrich Germing, MD9*

1Hospital Clínico Universitario de Salamanca, Salamanca, Spain
2RTI Health Solutions, Research Triangle Park, NC
3RTI Health Solutions, Durham, NC
4Bristol Myers Squibb, Madison, NJ
5Bristol Myers Squibb, Princeton, NJ
6RTI Health Solutions, Lyon, France
7Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
8Bristol Myers Squibb, Uxbridge, United Kingdom
9Department of Hematology, Oncology and Clinical Immunology, University Medical Center Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany

Richard Newcomb, MD1,2*, Hermioni L Amonoo, MD2,3, Alison R Kavanaugh4*, James Fausto, MD5*, Jason A Webb, MD6*, Joseph A Greer, PhD2,4*, Jennifer S Temel2,4*, Porsha Lark4*, Dustin J Rabideau2,4*, Thomas W. LeBlanc, MD, MA, MS7, Stephanie J. Lee, MD, MPH8 and Areej El-Jawahri, MD2,4

1Massachusetts General Hospital, Winthrop, MA
2Harvard Medical School, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Massachusetts General Hospital, Boston, MA
5University of Washington, Seattle, WA
6Oregon Health and Sciences University, Portland, OR
7Duke Cancer Institute, Hillsborough, NC
8Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Kimberly Guinan, MSc1*, Laurie Demers-Rozon, MSc1*, Monika Ham, MSc1*, Yoann Brassard, MSc, MBA2*, Nancy Paul Roc, MSc2*, Paola Lembo, PhD2*, Grace Christou, MD, MSc, FRCPC3*, Christopher Lemieux, MD4, Stephane Barakat, PhD2*, Yanqing Xu5*, Mathieu Pelletier, BSc1,6* and Jean Lachaine, PhD1*

1PeriPharm Inc., Montreal, QC, Canada
2AbbVie Corporation, Saint-Laurent, QC, Canada
3Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
4Centre intégré de cancérologie, CHU de Québec - Université Laval, Québec, QC, Canada
5AbbVie, Inc., Health Economics and Outcomes Research – Oncology, Chicago, IL
6Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada

Tejaswini Dhawale, MD1,2, Valentina Nardi, MD3,4*, Charlotte Wang, MD, PhD2,5*, Adam Bard5*, Natalia Essigmann6*, Daniel Leonard, MD, PhD5*, Timothy Aaron Graubert, MD2,7 and Amir T. Fathi, MD2,8

1MGH, West Newton, MA
2Harvard Medical School, Boston, MA
3Pathology Division, Harvard Medical School, Boston, MA
4Department of Pathology, Massachusetts General Hospital, Boston, MA
5Massachusetts General Hospital, Boston, MA
6Newton Wellesley Hospital and Clinics, Newton, MA
7Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
8Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA

Rupayan Kundu, MD1*, Xiaoying Chen2*, Wei Wei3*, Debolina Pramanik, MD1*, Yash Agarwal, MBBS4*, Arjun Chatterjee, MD5*, Akriti G. Jain, MD6, Abhay Singh, MD, MPH6, Aaron T. Gerds, MD, MS6, Hetty E. Carraway, MD, MBA6, Moaath K. Mustafa Ali, MD, MPH6, John C. Molina, MD, MEd6, Sophia Balderman, MD6* and Sudipto Mukherjee, MD, PhD, MPH6

1Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH
2Cleveland Clinic, Quantitative Health Sciences, Lerner Research Institute, Cleveland, OH
3Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
4College of Medicine and Sagore Dutta Hospital, Kolkata, India
5Cleveland Clinic Foundation, Cleveland, OH
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

*signifies non-member of ASH